Skip to content

SPP closes at 5pm AWST Wed 25th Nov 2026  Learn more    

Supplementary Prospectus issued

PILL has issued a Supplementary Prospectus following execution of an agreement to commercialise its diabetic kidney disease diagnostic test in China and reduced its minimum subscription to $3 million.